secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001140361-23-028551
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics stockholders elect director and ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Bryant E. Fong elected Class I director with 104,032,764 votes for, 43,796,163 withheld, 31,645,337 broker non-votes.
- Ratification of CohnReznick LLP as independent auditor for FY 2023: 178,835,482 for, 407,959 against, 230,823 abstain.
- Quorum of 179,474,264 shares represented out of 222,249,295 outstanding as of April 10, 2023 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/0001140361-23-028551-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/brhc20054100_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-028551

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer